Lilly Reports New Taltz and Zepbound Phase 3b Study Insights
Indianapolis, Indiana, USA, October 9, 2026 Eli Lilly and Company has announced new exploratory findings from its Phase 3b...
Vaccines, Blood & Biologics
Everest Medicines Expands Global mRNA Cancer Vaccine Research
Shanghai, China, October 9, 2026 Everest Medicines has strengthened its global research and development capabilities by appointing two experienced...
Antengene Advances ATG-207 for Autoimmune Disease Research
Shanghai and Hong Kong, China, October 9, 2026 Antengene Corporation Limited has announced that it will present new preclinical...
cAMPfield: Prifemilast Wins Phase 3 Psoriasis Trial Results
San Diego, California, USA, October 9, 2026 cAMPfield Therapeutics has announced positive Phase 3 clinical trial results for prifemilast,...
Innovent’s SYCUME Meets Phase 3 Goal in Inactive TED
San Francisco, California, U.S., and Suzhou, China, October 8, 2026 Innovent Biologics has announced positive Phase 3 results for...
Ultragenyx to Sell Rare Disease Voucher for $210 Million
Novato, California, U.S., October 7, 2026 Ultragenyx Pharmaceutical Inc. has entered into a definitive agreement to sell its Rare...
Alpheus Medical Opens New Trial for Butterfly Glioblastoma
Chanhassen, Minnesota, U.S., October 8, 2026 Alpheus Medical has announced the initiation of a new clinical trial evaluating its...
Clarity Pharmaceuticals Completes SECuRE Trial Enrollment
Sydney, Australia, October 8, 2026 Clarity Pharmaceuticals has achieved the recruitment target for the main group of the Cohort...
SOPHiA GENETICS and Myriad Advance Prostate Cancer Test
Boston, Massachusetts, U.S., October 8, 2026 SOPHiA GENETICS and Myriad Genetics have announced a new collaboration to advance a...
Consano Bio to Highlight C-1101 for Sciatica at Conferences
Burlington, Massachusetts, U.S., October 8, 2026 Consano Bio, Inc., a clinical-stage biotechnology company developing innovative therapies for painful orthopedic...